Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 1 |
2018 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
Mucolipidosis type III, a series of adult patients.
J Inherit Metab Dis. 2018 Sep;41(5):839-848. doi: 10.1007/s10545-018-0186-z. Epub 2018 Apr 27.
J Inherit Metab Dis. 2018.
PMID: 29704188
Free PMC article.
BACKGROUND: Mucolipidosis type III alpha/beta or gamma (MLIII) are rare autosomal recessive diseases, in which reduced activity of the enzyme UDP-N-acetyl glucosamine-1-phosphotransferase (GlcNAc-PTase) leads to intra-lysosomal accumulation of different substrates. ...METH …
BACKGROUND: Mucolipidosis type III alpha/beta or gamma (MLIII) are rare autosomal recessive diseases, in which reduced activity of th …
Benign or not benign? Deep phenotyping of liver Glycogen Storage Disease IX.
Fernandes SA, Cooper GE, Gibson RA, Kishnani PS.
Fernandes SA, et al.
Mol Genet Metab. 2020 Nov;131(3):299-305. doi: 10.1016/j.ymgme.2020.10.004. Epub 2020 Oct 10.
Mol Genet Metab. 2020.
PMID: 33317799
Free PMC article.
It is caused by a deficiency in enzyme phosphorylase kinase (PhK), a complex, hetero-tetrameric enzyme comprised of four subunits - alpha, beta, gamma, and delta - each with tissue specific isoforms encoded by different genes. Until the recent availability of gene panels a …
It is caused by a deficiency in enzyme phosphorylase kinase (PhK), a complex, hetero-tetrameric enzyme comprised of four subunits - alpha, b …
Item in Clipboard
Effects of immune modulation therapy in the first Croatian infant diagnosed with Pompe disease: a 3-year follow-up study.
Markic J, Polic B, Stricevic L, Metlicic V, Kuzmanic-Samija R, Kovacevic T, Ivkosic IE, Mestrovic J.
Markic J, et al.
Wien Klin Wochenschr. 2014 Feb;126(3-4):133-7. doi: 10.1007/s00508-013-0475-3. Epub 2013 Dec 14.
Wien Klin Wochenschr. 2014.
PMID: 24337590
Pompe disease is a storage disorder characterized by deficient or absent activity of the enzyme acid alpha-glucosidase. ...High antibody titers complicate therapeutic management, and those patients have a worse clinical outcome of enzyme replacement therapy (ERT).Four year …
Pompe disease is a storage disorder characterized by deficient or absent activity of the enzyme acid alpha-glucosidase. ...High antib …
Item in Clipboard
Cite
Cite